Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Rena Therapeutics

Explore full profile

Creating new nucleic acid drugs realized by third platform technology

Tokyo, JapanFounded 2015Biotech & Life Sciences
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Rena Therapeutics and the history behind them.

About Rena Therapeutics

Rena Therapeutics specializes in developing cutting-edge gene therapy solutions aimed at treating rare genetic disorders. The company operates in the biotechnology sector, focusing on advanced genome editing technologies to create effective treatments. Rena Therapeutics primarily serves patients suffering from rare diseases, collaborating with healthcare providers and research institutions to bring innovative therapies to market. The business model revolves around research and development, clinical trials, and eventual commercialization of gene therapies. Revenue is generated through partnerships, licensing agreements, and sales of approved therapies.

Source: Dealroom company data

At a glance

Founded
2015
Headquarters
Tokyo, Japan
Sector
Biotech & Life Sciences

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • DBJ Capital
  • Kanagawa Science Park
  • INCJ
  • Nippon Shokubai
Employees 12 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇯🇵 Japan100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Rena Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rena Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.